Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rinsho Shinkeigaku ; 58(1): 30-34, 2018 Jan 26.
Artigo em Japonês | MEDLINE | ID: mdl-29269695

RESUMO

A 43-year-old man without a previous episode of uveitis presented with slowly progressive neurological symptoms that appeared within the past year such as dysarthria, ataxic gait, and behavioral changes. Brain MRI findings showed atrophic lesions in the brainstem and cerebellum. Because these clinical symptoms and abnormal MRI findings indicated spinocerebellar degeneration as the initial diagnosis, he was admitted to our hospital. On admission, we noticed that he had non-neurological manifestations of Behçet disease, such as stomatitis, genital ulcers, and folliculitis. HLA-B51 was positive. He also showed pleocytosis (29 cells/mm3, predominantly mononuclear cells) and elevated cerebrospinal fluid (CSF) IL-6 levels (213 pg/ml), hence he was diagnosed with chronic progressive neuro-Behçet disease (CPNBD). The therapeutic effect of a high-dose intravenous methylprednisolone pulse (1,000 mg/day for 3 days) and methotrexate (maximum dosage, 16 mg/week) was poor against both neurological symptoms and CSF findings. Intravenous infliximab therapy (5 mg/kg, 2 weeks) dramatically decreased CSF IL-6 levels (13 pg/ml) but clinical symptoms remained unchanged. MRI findings of extensive cerebral atrophy and increased CSF IL-6 levels at the pretreatment time point reflected irreversible neurological involvement in CPNBD. For cases with progressive psychiatric symptoms and cerebellar ataxia in the early stage of the disease, skin manifestations should be examined immediately, CSF IL-6 levels measured, and immunosuppressive therapy initiated before CPNBD progresses to brainstem atrophy.


Assuntos
Síndrome de Behçet/diagnóstico , Síndrome de Behçet/tratamento farmacológico , Encéfalo/patologia , Infliximab/administração & dosagem , Interleucina-6/líquido cefalorraquidiano , Adulto , Atrofia , Síndrome de Behçet/líquido cefalorraquidiano , Síndrome de Behçet/patologia , Biomarcadores/líquido cefalorraquidiano , Doença Crônica , Progressão da Doença , Humanos , Masculino , Resultado do Tratamento
2.
Neuroradiol J ; 30(2): 168-171, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28059630

RESUMO

We present three cases of anomalous origin of the left vertebral artery (LVA) detected during the evaluation of stroke. The VA usually enters the transverse foramen of the sixth cervical vertebra (C6), but an anomalous LVA originating from the aorta frequently enters at a higher level. In our series, ultrasound of the LVA showed entry at C4 in two patients and at C5 in one patient. These findings suggested anomalous LVA origin, and three-dimensional computed tomography demonstrated the LVA arising from the aorta proximal to the left subclavian arteries. Carotid duplex ultrasound is useful for the diagnosis of this anomaly.


Assuntos
Artéria Subclávia/diagnóstico por imagem , Ultrassonografia , Malformações Vasculares/patologia , Artéria Vertebral/diagnóstico por imagem , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Artéria Subclávia/anormalidades , Malformações Vasculares/diagnóstico por imagem , Artéria Vertebral/anormalidades
3.
Rinsho Shinkeigaku ; 56(11): 759-763, 2016 11 29.
Artigo em Japonês | MEDLINE | ID: mdl-27773903

RESUMO

A 40-year-old man presented with a series of generalized tonic-clonic seizures after febrile illness. He developed status epilepticus and required mechanical ventilation with anesthetics. Steroid pulse, intravenous immunoglobulin, and immunoadsorption therapy were administrated, and the status epilepticus improved; however, drug-resistant seizures remained. Despite the use of several antiepileptic drugs, seizures frequently occurred. Additional administration of potassium bromide resulted in significant suppression of seizures. Potassium bromide is regarded as an effective medication for pediatric refractory epilepsy after encephalitis. The present case is considered to be new-onset refractory status epilepticus (NORSE) syndrome based on clinical features, and potassium bromide could be effective in treating adult refractory epilepsy, such as NORSE syndrome.


Assuntos
Brometos/administração & dosagem , Epilepsia Resistente a Medicamentos/tratamento farmacológico , Compostos de Potássio/administração & dosagem , Estado Epiléptico/tratamento farmacológico , Adulto , Humanos , Masculino , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...